The ticagrelor market covers the drug ticagrelor which is an oral, reversible, P2Y12 platelet aggregation inhibitor. Ticagrelor helps to prevent platelets from clumping together and forming clots. It is mainly used for reducing thrombotic cardiovascular events such as heart attack or stroke in patients with acute coronary syndrome or history of myocardial infarction. Ticagrelor market provides...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian